{"disease":{"id":"nonalcoholic-fatty-liver-disease","name":"nonalcoholic fatty liver disease"},"drugs":{"marketed":[],"pipeline":[{"drug_id":"pf-05221304","indication_name":"Nonalcoholic fatty liver disease (NAFLD)","indication_type":"pipeline","phase":"Phase 2","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"PF-05221304","generic_name":"pf-05221304","company_name":"Pfizer Inc.","drug_phase":"discontinued","molecular_target":"Acetyl-CoA carboxylase (ACC1 and ACC2)","drug_class":"Acetyl-CoA carboxylase inhibitor","quality_score":27,"revenue":null,"mechanism":"Selective inhibitor of acetyl-CoA carboxylase (ACC1/ACC2) that reduces hepatic lipogenesis and promotes fatty acid oxidation."}],"offLabel":[],"totalMarketed":0,"totalPipeline":1},"trials":{"data":[{"nct_id":"NCT03847116","title":"Alcohol Consumption and Type 2 Diabetes Mellitus Risk in Nonalcoholic Fatty Liver Disease","phase":"","overall_status":"COMPLETED","enrollment_count":14014,"lead_sponsor_name":"Ningbo No. 1 Hospital","has_results":false},{"nct_id":"NCT05550688","title":"Weight Gain After Smoking Cessation and NAFLD","phase":"","overall_status":"COMPLETED","enrollment_count":12941,"lead_sponsor_name":"Ningbo No. 1 Hospital","has_results":false},{"nct_id":"NCT03525769","title":"Screening With FibroTouch for Advanced Liver Fibrosis in NAFLD Patients With Underlying Type 2 Diabetes","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT07248371","title":"Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":6266,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT04371042","title":"PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT07070362","title":"Digital Early Warning System for Acute Lung Injury in Liver Surgery","phase":"","overall_status":"RECRUITING","enrollment_count":4000,"lead_sponsor_name":"Beijing Tsinghua Chang Gung Hospital","has_results":false},{"nct_id":"NCT03366987","title":"Nonalcoholic Fatty Liver Disease is Associated With Increased Atrial Fibrillation Risk in an Elderly Chinese Population","phase":"","overall_status":"COMPLETED","enrollment_count":2000,"lead_sponsor_name":"Ningbo No. 1 Hospital","has_results":false},{"nct_id":"NCT06115876","title":"Kuwait Adult Diabetes Epidemiological Multidisciplinary (KADEM) Program","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Dasman Diabetes Institute","has_results":false},{"nct_id":"NCT03566173","title":"Association Between Nonalcoholic Fatty Liver Disease and Acute Pancreatitis","phase":"","overall_status":"COMPLETED","enrollment_count":1662,"lead_sponsor_name":"Ningbo No. 1 Hospital","has_results":false},{"nct_id":"NCT06368882","title":"Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease（OCEAN PROJECT）","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"First Affiliated Hospital of Wenzhou Medical University","has_results":false},{"nct_id":"NCT04820556","title":"Gut Microbiota in Chronic Noncommunicable Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":1084,"lead_sponsor_name":"National Medical Research Center for Therapy and Preventive Medicine","has_results":false},{"nct_id":"NCT05697991","title":"Non-Alcoholic Fatty Liver Disease in a Saudi Cohort With Type 2 Diabetes Mellitus","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"King Saud University","has_results":false},{"nct_id":"NCT05625750","title":"Observational Study About Patients Diagnosed With NAFLD","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Xiangya Hospital of Central South University","has_results":false},{"nct_id":"NCT07149571","title":"To Explore the Value of New MR Technology in Non-invasive Quantitative Assessment of Systemic Metabolism, Disease Status and Prognosis in Patients With Metabolic-Associated Fatty Liver Disease","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT05877547","title":"A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":381,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT03248882","title":"Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":305,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT05583344","title":"Phase 2b Study of GSK4532990 in Adults With NASH","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":284,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT04321031","title":"Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":256,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT02781584","title":"Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":220,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT07237750","title":"iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss","phase":"NA","overall_status":"RECRUITING","enrollment_count":216,"lead_sponsor_name":"Liu Yan","has_results":false},{"nct_id":"NCT04772352","title":"Effects of Febuxostat for Lowering Uric Acid in NAFLD Patients With Gout","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Ningbo No. 1 Hospital","has_results":false},{"nct_id":"NCT07182136","title":"The Impact of Hepatic Steatosis on Survival After Pancreaticoduodenectomy","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Wei-Hsun Lu","has_results":false},{"nct_id":"NCT04801849","title":"Vitamin E Dosing Study","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","has_results":true},{"nct_id":"NCT05330923","title":"Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver Disease","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT03486899","title":"A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":197,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":true},{"nct_id":"NCT03375580","title":"Therapeutic Effects of Compound Zhenzhu Tiaozhi Capsules in NAFLD","phase":"NA","overall_status":"UNKNOWN","enrollment_count":196,"lead_sponsor_name":"The First Affiliated Hospital of Guangdong Pharmaceutical University","has_results":false},{"nct_id":"NCT04906421","title":"Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":168,"lead_sponsor_name":"Sagimet Biosciences Inc.","has_results":true},{"nct_id":"NCT03059446","title":"Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":167,"lead_sponsor_name":"Tobira Therapeutics, Inc.","has_results":true},{"nct_id":"NCT07146815","title":"PolyCystic Ovary Syndrome as Suggested Risk Group for Non-Alcoholic Fatty Liver Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":157,"lead_sponsor_name":"Ziekenhuis Oost-Limburg","has_results":false},{"nct_id":"NCT03486912","title":"A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":155,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":true},{"nct_id":"NCT06705868","title":"Chrononutrition/ Chronotoxicity Intervention in People With Metabolic-associated Steatotic Liver Disease.","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Cyprus University of Technology","has_results":false},{"nct_id":"NCT04944992","title":"A Study of Efinopegdutide (MK-6024) in Participants With Nonalcoholic Fatty Liver Disease (NAFLD) (MK-6024-001)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":145,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT06257732","title":"Different Exercise Modalities in the Treatment of NAFLD and Their Impact on Myokines","phase":"NA","overall_status":"UNKNOWN","enrollment_count":144,"lead_sponsor_name":"Yeditepe University","has_results":false},{"nct_id":"NCT01045499","title":"LAGB as a Treatment for Morbid Obesity in Adolescents","phase":"NA","overall_status":"COMPLETED","enrollment_count":137,"lead_sponsor_name":"Jeffrey L Zitsman, MD","has_results":true},{"nct_id":"NCT02217345","title":"Growth Hormone and Intrahepatic Lipid Content in Patients With Nonalcoholic Fatty Liver Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":131,"lead_sponsor_name":"Massachusetts General Hospital","has_results":true},{"nct_id":"NCT03459079","title":"Lanifibranor in Patients With Type 2 Diabetes & Nonalcoholic Fatty Liver Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":128,"lead_sponsor_name":"University of Florida","has_results":true},{"nct_id":"NCT06482112","title":"Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (MK-6024-016)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":124,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT07168551","title":"Is There a Relationship Between Uric Acid Level and Liver Fibrosis in Obese Patients","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":111,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT07363707","title":"A Study Between Dapagliflozin and Empagliflozin Effect on NAFLD in Patients With Type 2 Diabetes.","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":108,"lead_sponsor_name":"Beni-Suef University","has_results":false},{"nct_id":"NCT03572465","title":"Quantitative Ultrasound Techniques for Diagnosis of Nonalcoholic Steatohepatitis","phase":"","overall_status":"RECRUITING","enrollment_count":102,"lead_sponsor_name":"Centre hospitalier de l'Université de Montréal (CHUM)","has_results":false},{"nct_id":"NCT03656744","title":"A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":101,"lead_sponsor_name":"HighTide Biopharma Pty Ltd","has_results":true},{"nct_id":"NCT06739486","title":"Efficacy of Sodium Glucose Cotransporter 2 Inhibitors on Non-Alcoholic Fatty Liver Disease","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT05497765","title":"An Intervention Study of Compound Silymarin in Patients With Non-alcoholic Fatty Liver Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":94,"lead_sponsor_name":"Guangzhou Medical University","has_results":false},{"nct_id":"NCT05523648","title":"Clinical Effects of Ganshuang Combined TDF to Treat CHB and NAFLD","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":92,"lead_sponsor_name":"Sichuan Leshan Traditional Chinese Medicine Hospital","has_results":false},{"nct_id":"NCT03998514","title":"A Phase 1a/1b Study of CB4211 in Healthy Non-obese Subjects and Subjects With Nonalcoholic Fatty Liver Disease","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":88,"lead_sponsor_name":"CohBar, Inc.","has_results":false},{"nct_id":"NCT04988230","title":"Time Restricted Feeding on Nonalcoholic Fatty Liver Disease ( TREATY-FLD )：a 12-month Follow-up Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":88,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT03786523","title":"Time Restricted Feeding on Nonalcoholic Fatty Liver Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":88,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT03467217","title":"Losartan for the Treatment of Pediatric NAFLD","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":83,"lead_sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","has_results":true},{"nct_id":"NCT04399538","title":"Study of Pharmacodynamics and Safety of DGAT2i and ACCi Coadministered in Participants With Sponsor-defined Presumed Non Alcoholic Steatohepatitis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":75,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT07278128","title":"Evaluation of the Therapeutic Effects of Curcumin on Changes in Lipid, Metabolic, and Hormonal Profiles, Liver Enzyme Activity, and Ultrasonography Morphology of the Liver in Women With Polycystic Ovary Syndrome and Nonalcoholic Fatty Liver Disease: A Double-blind, Placebo-controlled Clinical Trial","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":74,"lead_sponsor_name":"Fateme Moshirenia","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}